Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy (Q83465806)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

chronic myeloid leukemia

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Mathieu Molimard

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Gareth Gerrard

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Amr R Ibrahim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Lina Eliasson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Jane F Apperley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Dragana Milojkovic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Marco Bua

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Francois-Xavier Mahon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Kasia Kozlowski

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Christos Paliompeis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Letizia Foroni

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Jamshid S Khorashad

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Alex Bazeos

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Alistair Reid

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Katayoun Rezvani

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

John Goldman

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

David Marin

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

23 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

3733-3736

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia.

23 January 2020

cites work

1 reference

12 December 2020

Adherence to therapy with oral antineoplastic agents

1 reference

12 December 2020

Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring

1 reference

12 December 2020

Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase

1 reference

12 December 2020

Adherence to Medication

1 reference

12 December 2020

Patient adherence and persistence with oral anticancer treatment

1 reference

12 December 2020

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

1 reference

12 December 2020

European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor.

1 reference

12 December 2020

Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy

1 reference

12 December 2020

Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.

1 reference

12 December 2020

Compliance declines between clinic visits

1 reference

12 December 2020

Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis

1 reference

12 December 2020

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

1 reference

12 December 2020

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study.

1 reference

12 December 2020

10.1182/BLOOD-2010-10-309807

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21346253%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference